A new trading day began on Monday, with Ocugen Inc (NASDAQ: OCGN) stock price down -0.34% from the previous day of trading, before settling in for the closing price of $0.68. OCGN’s price has ranged from $0.51 to $2.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 1.96% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -23.75%. With a float of $286.75 million, this company’s outstanding shares have now reached $291.37 million.
In an organization with 95 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -123.95%, operating margin of -1350.36%, and the pretax margin is -1333.02%.
Ocugen Inc (OCGN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 24.63%. The most recent insider transaction that took place on Nov 26 ’24, was worth 9,095. In this transaction Director of this company bought 10,000 shares at a rate of $0.91, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Director bought 25,000 for $0.91, making the entire transaction worth $22,848. This insider now owns 75,000 shares in total.
Ocugen Inc (OCGN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -23.75% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Here are Ocugen Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 48.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Let’s dig in a bit further. During the last 5-days, its volume was 3.64 million. That was inferior than the volume of 4.11 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.23%. Additionally, its Average True Range was 0.07.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 32.10%, which indicates a significant decrease from 62.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.46% in the past 14 days, which was higher than the 83.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6458, while its 200-day Moving Average is $0.9698. However, in the short run, Ocugen Inc’s stock first resistance to watch stands at $0.6897. Second resistance stands at $0.7022. The third major resistance level sits at $0.7206. If the price goes on to break the first support level at $0.6588, it is likely to go to the next support level at $0.6404. The third support level lies at $0.6279 if the price breaches the second support level.
Ocugen Inc (NASDAQ: OCGN) Key Stats
With a market capitalization of 197.72 million, the company has a total of 292,014K Shares Outstanding. Currently, annual sales are 4,060 K while annual income is -54,050 K. The company’s previous quarter sales were 760 K while its latest quarter income was -13,880 K.
